Boston-based Author Health, a hybrid care platform for Medicare Advantage members with serious mental illness and substance use disorders.
Share: email Subscribe
Weekly Top Stories Tue, 04 Jul 2023
We have 28 articles this week, #Lilly to Buy European ADC Player Emergence Therapeutics #Baudax Bio Acquires TeraImmune, Inc. #Univercells Technologies Acquired by Donaldson Company #Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp. #Immunome and Morphimmune Announce a Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies #Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation
Editor's Choice
1. 
 Author Health Launches with $115M to Aid Seniors’ Mental Health
2. 
 Iodine Software, OpenAI Partner to Resolve Revenue Leakage
3. 
 New AI ECG Algorithm Beats Standard Approaches for Detecting Heart Attacks
4. 
 Abbott, American Diabetes Association Launches Therapeutic Nutrition Program for People with Diabetes
5. 
 Why Interoperability is Key to Successful Digital Pharma Solutions
Top 10 M&A Transactions
6. 
 Lilly to Buy European ADC Player Emergence Therapeutics
7. 
 Baudax Bio Acquires TeraImmune, Inc.
8. 
 Univercells Technologies Acquired by Donaldson Company
9. 
 Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp.
10. 
 Immunome and Morphimmune Announce a Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies.
11. 
 Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation.
12. 
 Lilly to Acquire Sigilon Therapeutics
13. 
 Enovis™ Completes Acquisition of Novastep®
14. 
 Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination
15. 
 Precision for Medicine Acquires Baseline Controls, Expanding the Company’s End-to-End Manufacturing Solutions for Life Science Companies
Top 4 Venture Funding
16. 
 Define Ventures Seeks to Invest in Digital Health After $460M Raise
17. 
 Alfie Health Raises $2.1M for AI-Powered, Virtual Obesity Clinic
18. 
 Augmented Reality Spine Surgery Platform Augmedics Scores $82.5M
19. 
 Flywheel Secures $54M for Medical AI Imaging Platform
Top 3 Partnerships Announcements
20. 
 Lilly to Buy Diabetes Cell Therapy Partner Sigilon for Just Over $300M.
21. 
 Mark Cuban Cost Plus Drug Company Partners with Male Fertility Platform
22. 
 Headspace, Virgin Pulse Expand Partnership to Enhance Employer Offering
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us